STE · 8-K · 20261104PR070220

Operating Expense Trends

STERIS plc · 2026-11-04 · Importance 68 · Surprise 82

Second-quarter SG&A expense increased to $366.0 million from $349.7 million, a 4.7% rise. Research and development expense increased 11.7% to $31.5 million from $28.2 million. Restructuring expense was $19.1 million compared with $2.2 million a year earlier; the separate targeted plan generated approximately $25 million of second-quarter charges.